What the Israel Innovation Authority does

The Israel Innovation Authority (IIA) is a government body that distributes grants and incentives to companies conducting R&D in Israel. Its mission is to grow the country's innovation ecosystem, retain talent, and attract foreign companies to set up research centers locally rather than elsewhere in the region or globally. The Authority operates multiple grant programs, each with different size caps, reimbursement percentages, and eligibility rules.

For a multinational opening a software, biotech, hardware, or advanced services R&D center in Israel, the IIA programs can offset a meaningful portion of first-year costs. Some multinationals see 30 to 40% of employee salary spend reimbursed. Others claim back equipment, software licenses, and contractor fees. The grants don't require equity stakes or repayment guarantees, though they do come with reporting obligations and, if the technology is commercialized, a modest royalty commitment.

One clarification worth stating upfront. The IIA grants are distinct from Israel's R&D tax credits (which are separate, and handled by tax authorities). They are also distinct from innovation visas or fast-track labor approvals, which are immigration matters. The IIA grants are pure R&D reimbursement, and they sit alongside those other incentives.

Who qualifies for IIA grants

To be eligible for any IIA program, your company must satisfy a short list of hard requirements:

• Israeli legal entity. You must register as a corporation, partnership, or branch office in Israel. You cannot apply as a foreign entity doing business in Israel. Most multinationals set up a subsidiary.
• Israeli employees. The R&D team must include Israeli citizens or permanent residents. The IIA does not fund pure support work or non-R&D roles, though salary for Israeli software engineers, researchers, or engineering managers counts in full.
• R&D work. The project must involve original research, experimental development, or technological innovation. Routine software maintenance, customer support, or sales functions do not qualify. Translation and localization work do not qualify.
• Local work done in Israel. The approved work must be performed in Israel. This is typically verified through time records, invoices, and payroll attestations.

Foreign-owned subsidiaries are the norm. The IIA does not require Israeli shareholders or Israeli board members. Many multinationals open an Israeli subsidiary 100% owned by the parent and staff it with Israeli hires plus expats on work visas.

Main grant tracks open to multinationals

The IIA operates several parallel programs. These four are the most commonly used by foreign R&D centers:

For a typical multinational R&D subsidiary hiring 10 to 50 Israeli engineers in year one, the Multinational R&D program is the most straightforward. It explicitly targets foreign companies opening or expanding Israeli centers, and the reimbursement rate of 30 to 50% reflects the government's interest in attracting and retaining this work. A year-one budget of 3 million ₪ in approved R&D spend could yield 900,000 to 1,500,000 ₪ in grants.

The R&D Fund is simpler to apply for and has lighter paperwork, but the reimbursement rate is lower (20 to 30%). It is a good fit for companies already established in Israel seeking incremental expansion.

KAMIN programs suit companies partnering with Israeli universities or research institutes. For example, if your R&D center collaborates with the Technion or Tel Aviv University on a shared project, KAMIN can fund your portion of the work.

Magnet programs are consortium plays. They are large, multi-year, and competitive. Your company would join 5 to 10 other companies, universities, and research bodies around a shared theme (autonomous driving, cybersecurity, etc.). Only select multinationals pursue this route, and the application cycle is rigid.

What expenses qualify and how reimbursement works

The IIA reimburses "approved R&D costs" as percentages of your submitted budget. This typically includes:

• Salaries and benefits for Israeli R&D staff (engineers, researchers, some managers).
• Equipment and software licenses directly used in the R&D work.
• Contractor or consultant fees for specialized technical work.
• Travel and materials consumed in the research process.

It does not include general overhead, marketing, sales, rent or facilities (though some jurisdictions allow a partial allocation), or work performed outside Israel.

Reimbursement is post-hoc. You submit quarterly or annual reports with evidence of spend (payroll records, invoices, time logs). The IIA audits and approves. You then receive the reimbursement as a one-time grant transfer, or in some programs, as a series of draws tied to milestones.

Royalty obligations and IP ownership

Here is an important detail. Most IIA grants come with a modest royalty clause. If the research results in a commercialized product or service, and it generates revenue, your company pays a small royalty back to the IIA. The royalty is typically 2 to 5% of net revenue from commercialized IP that the grant helped develop.

This royalty is deferred. You pay it only if and when the product sells, and only on the incremental revenue from that product. It is not owed if the research leads nowhere, or if the IP is used solely internally.

Ownership of intellectual property remains with your company. The IIA does not claim equity, shares, or IP rights. It only asks for a revenue share if the grant-funded work becomes a commercial product.

Periphery zone bonuses and recent 2024-2026 changes

In recent years, the IIA has raised reimbursement caps and expanded incentives for work done in Israel's development zones and periphery regions. If your R&D center is based outside the Tel Aviv metropolitan area, you may qualify for a bonus on top of the base grant rate. Bonus can range from 5 to 15 percentage points, depending on the zone and program.

For example, an R&D center in the Negev or Upper Galilee region might receive 40% reimbursement under Multinational R&D instead of 30%, or even 50% in some cases. This is a recent change designed to distribute R&D activity beyond the central region and grow local tech ecosystems in underserved areas.

The 2024-2026 reform cycle also softened some startup eligibility rules. Companies less than 3 years old can now apply to certain tracks if they can demonstrate significant R&D spend and a viable innovation roadmap. Previously, established revenue was more strongly favored.

Application timeline and approval process

The typical IIA application cycle runs as follows:

• Intake and pre-check (weeks 1-2). You submit a preliminary application outlining your company, the R&D project, budget, and Israeli team size. The IIA's team confirms basic eligibility and advises if you should proceed to a full application.
• Full application (weeks 2-8). You prepare detailed R&D plans, technical descriptions, payroll records, equipment lists, and financial projections. A Hebrew-language consultant or law firm familiar with IIA applications can help here.
• IIA review (weeks 8-16). The Authority's in-house team evaluates the application. They may ask for clarifications, request site visits, or request references from your Israeli employees.
• Approval (weeks 16+). Once approved, you receive a formal grant contract. You then execute the project and report quarterly or annually, at which point reimbursement is processed.

The entire process from intake to first reimbursement typically takes 4 to 6 months. Some complex applications take longer. It is not uncommon for the IIA to request supplementary documents or to negotiate the final grant amount downward if the budget seems inflated.

What disqualifies you or significantly narrows your chances

The IIA has a few strong disqualifiers and risk factors:

• Low-tech or non-innovative work. If your R&D is routine engineering or optimization of existing technology, it may be classified as low-innovation and rejected or capped at a very low level.
• No Israeli employees. You must have genuine Israeli staff. Hiring Israelis solely on paper or as contractors, without real R&D contribution, is a compliance risk.
• Work outside Israel. If the approved project work is done partly in Israel and partly in a foreign office, the IIA requires a clear allocation. They will not fund the foreign portion.
• Prior compliance issues. If your company has a history of misreporting to the IIA or other Israeli government bodies, approval odds are very low.
• Sanctioned countries or industries. If your parent company is domiciled in, or has operations in, a country under Israeli or international sanctions, eligibility may be voided. This is rare but worth confirming upfront.

Weak R&D narratives also reduce chances. If your application reads like a cost-shifting mechanism rather than a genuine innovation effort, the IIA will flag it. The Authority is sophisticated and sees hundreds of applications per year. Substance matters.

Next steps for a foreign R&D center

If you are planning or have recently opened an Israeli R&D subsidiary, here is the rough sequence:

1. Register the Israeli subsidiary and hire or contract your first Israeli R&D staff.
2. Engage a Hebrew-speaking consultant or law firm with IIA experience to scope which programs fit your budget and timeline.
3. Gather payroll, equipment, and project documentation for your first 3 to 6 months of operation.
4. Submit a pre-check application to gauge approval likelihood and cycle time.
5. Prepare the full application, which typically requires 4 to 8 weeks of documentation and translation work.
6. Expect the IIA review cycle to take another 8 to 12 weeks.

Timing matters. Companies that apply early in their Israeli setup phase often have an easier approval path because the R&D narrative is fresher and the hiring ramp is clearer. Applying 18 months after the subsidiary was formed, with vague project scope or shifting teams, is harder to justify to the Authority.

Final checklist before you apply

Make sure you have:

• Israeli subsidiary registered with the Ministry of Industry.
• At least 3 to 5 Israeli full-time or contractor R&D staff committed to the project.
• A clear R&D roadmap for the next 12 to 24 months with measurable outcomes.
• Documented payroll, equipment purchase agreements, and project timelines.
• A Hebrew translator or dedicated local consultant to guide the application.
• Clarity on which grant track fits best (usually Multinational R&D for foreign subsidiaries).

Disclaimer. This article is for informational purposes and is not legal or financial advice. IIA program rules, caps, and reimbursement rates change periodically. Consult an Israeli employment lawyer and an IIA specialist before committing budget or making hiring decisions. The numbers and percentages stated here are typical ranges as of mid-2026 and are not guarantees.